Yun-Ju Chen Selected Research

benzyloxycarbonyl- isoleucyl- glutamyl(O- tert- butyl)- alanyl- leucinal

9/2019

Proteasome Inhibitors Suppress ErbB Family Expression through HSP90-Mediated Lysosomal Degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Ju Chen Research Topics

Disease

29	Neoplasms (Cancer) 01/2021 - 12/2004
16	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2011
8	Hepatocellular Carcinoma (Hepatoma) 02/2019 - 01/2013
6	Carcinogenesis 01/2019 - 06/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2011
5	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2011
4	Macular Edema 07/2021 - 01/2016
4	Triple Negative Breast Neoplasms 11/2015 - 04/2013
3	Stroke (Strokes) 03/2022 - 05/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2013
3	Prostatic Neoplasms (Prostate Cancer) 06/2017 - 12/2004
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2016 - 07/2013
3	Muscular Dystrophies (Muscular Dystrophy) 02/2007 - 06/2002
2	Retinal Detachment (Retinal Detachments) 01/2022 - 01/2018
2	Diabetes Mellitus 07/2021 - 01/2013
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2011
2	Oncogene Addiction 01/2018 - 11/2013
2	Pain (Aches) 09/2014 - 11/2013
2	Colonic Neoplasms (Colon Cancer) 06/2008 - 07/2007
1	Anastomotic Leak 05/2022
1	Fibrosis (Cirrhosis) 02/2022
1	Infections 02/2022
1	Central Serous Chorioretinopathy 01/2022
1	Osteoporotic Fractures 01/2022
1	Uveal Effusion Syndrome 01/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Retinal Dystrophies 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021
1	Ocular Hypertension (Glaucoma, Suspect) 01/2021
1	Liver Neoplasms (Liver Cancer) 12/2020
1	Residual Neoplasm 12/2020
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Epilepsy (Aura) 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020
1	Thyroid Diseases (Thyroid Disease) 07/2019
1	Myasthenia Gravis 07/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2002
10	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2011
9	Lapatinib (GW572016)FDA Link 01/2021 - 04/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2011
4	Phosphotransferases (Kinase)IBA 01/2021 - 04/2012
4	FlavonoidsIBA 08/2014 - 06/2013
3	Ranibizumab (Lucentis)FDA Link 07/2021 - 02/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 10/2012
3	Pharmaceutical PreparationsIBA 09/2019 - 01/2013
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 03/2012
3	human ERBB2 proteinIBA 09/2016 - 04/2013
2	Retinaldehyde (Retinal)IBA 01/2022 - 07/2021
2	AndrogensIBA 01/2022 - 06/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
2	Proteasome InhibitorsIBA 09/2019 - 11/2013
2	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 01/2013
2	chrysinIBA 02/2019 - 06/2018
2	afliberceptIBA 01/2018 - 01/2016
2	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2016
2	SmokeIBA 01/2018 - 03/2012
2	MethyltransferasesIBA 01/2017 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 09/2016 - 11/2015
2	SERPIN-B5 (maspin)IBA 08/2016 - 09/2015
2	hepatitis B virus X proteinIBA 01/2016 - 04/2012
2	Small Interfering RNA (siRNA)IBA 01/2014 - 06/2008
2	AgarIBA 12/2013 - 06/2013
2	Mitogen-Activated Protein Kinase 14IBA 12/2013 - 06/2013
2	WYC02-9IBA 12/2013 - 06/2013
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2013 - 06/2012
2	NF-kappa B (NF-kB)IBA 11/2013 - 04/2012
2	Estrogen ReceptorsIBA 11/2013 - 06/2012
2	protoapigenoneIBA 07/2013 - 06/2013
2	Oncogene Proteins (Oncogene Protein)IBA 10/2012 - 06/2008
2	Gefitinib (Iressa)FDA Link 06/2011 - 01/2011
2	Dystroglycans (Dystroglycan)IBA 02/2007 - 10/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 02/2022
1	Hematoxylin (Haematoxylon)IBA 02/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 07/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	benzyloxycarbonyl- isoleucyl- glutamyl(O- tert- butyl)- alanyl- leucinalIBA 09/2019
1	Bortezomib (Velcade)FDA Link 09/2019
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 09/2019
1	Cholinergic ReceptorsIBA 07/2019
1	AntibodiesIBA 07/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2019

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2011
2	Canes (Cane) 03/2022 - 04/2019
2	Injections 07/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 12/2013 - 01/2013
1	Extracorporeal Shockwave Therapy 02/2022
1	Induced Hypothermia 01/2020
1	Rewarming 01/2020
1	Immunotherapy 01/2019